Minerva Neurosciences (NERV) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free NERV Stock Alerts $2.41 -0.03 (-1.23%) (As of 04/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Minerva Neurosciences Short Interest DataCurrent Short Volume30,500 sharesPrevious Short Volume40,300 sharesChange Vs. Previous Month-24.32%Dollar Volume Sold Short$73,810.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 15, 2024Outstanding Shares6,990,000 sharesFloat Size5,440,000 sharesShort Percent of Float0.56%Today's Trading Volume10,961 sharesAverage Trading Volume98,840 sharesToday's Volume Vs. Average11% Short Selling Minerva Neurosciences ? Sign up to receive the latest short interest report for Minerva Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNERV Short Interest Over TimeNERV Days to Cover Over TimeNERV Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Minerva Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202430,500 shares $73,810.00 -24.3%0.6%0.3 $2.42 3/31/202440,300 shares $103,974.00 +5.2%0.7%0.3 $2.58 3/15/202438,300 shares $106,857.00 -68.7%0.7%0.3 $2.79 2/29/2024122,400 shares $326,808.00 +416.5%2.3%1.1 $2.67 2/15/202423,700 shares $222,780.00 +25.4%0.5%0.3 $9.40 1/31/202418,900 shares $159,705.00 +33.1%0.4%0.5 $8.45 Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,200 shares $105,790.00 -55.6%0.3%0.5 $7.45 12/31/202332,000 shares $196,800.00 -30.6%0.7%1.3 $6.15 12/15/202346,100 shares $297,345.00 -37.4%1.0%2.3 $6.45 11/30/202373,600 shares $577,760.00 -6.5%1.5%3.6 $7.85 11/15/202378,700 shares $408,453.00 +53.7%1.6%4.2 $5.19 10/31/202351,200 shares $246,784.00 +4.5%1.1%2.4 $4.82 10/15/202349,000 shares $279,790.00 -17.0%1.0%1.8 $5.71 9/30/202359,000 shares $407,100.00 -20.3%1.2%1.3 $6.90 9/15/202374,000 shares $575,720.00 -7.9%1.5%0.1 $7.78 8/31/202380,300 shares $672,111.00 -21.1%1.9%0.1 $8.37 8/15/2023101,800 shares $911,110.00 -17.0%2.4%0.1 $8.95 7/31/2023122,700 shares $1.17 million +16.6%2.9%0.1 $9.51 7/15/2023105,200 shares $1.27 million -75.8%3.1%0.1 $12.07 6/30/2023434,000 shares $3.97 million +540.1%12.8%0.4 $9.14 6/15/202367,800 shares $496,296.00 -49.8%1.5%0.3 $7.32 5/31/2023135,000 shares $805,950.00 -54.6%2.9%0.7 $5.97 5/15/2023297,300 shares $1.91 million +263.5%6.4%1.6 $6.44 4/30/202381,800 shares $229,040.00 -22.7%1.8%0.5 $2.80 4/15/2023105,800 shares $241,224.00 +27.2%2.3%1.7 $2.28 3/31/202383,200 shares $133,120.00 -8.0%1.8%1.1 $1.60 3/15/202390,400 shares $157,296.00 -20.1%2.0%1 $1.74 2/28/2023113,200 shares $244,512.00 +15.9%2.5%1.2 $2.16 2/15/202397,700 shares $230,572.00 -4.0%2.2%1 $2.36 1/31/2023101,800 shares $243,302.00 -41.5%2.2%0.6 $2.39 1/15/2023174,100 shares $386,502.00 +20.2%3.8%1 $2.22 12/30/2022144,900 shares $230,391.00 -26.6%3.2%0.5 $1.59 12/15/2022197,300 shares $554,413.00 -21.5%4.3%0.6 $2.81 11/30/2022251,300 shares $889,602.00 +0.8%5.5%0.6 $3.54 11/15/2022249,200 shares $859,740.00 +79.3%5.5%0.1 $3.45 10/31/2022139,000 shares $368,350.00 -57.2%3.1%0 $2.65 10/15/2022324,600 shares $4.36 million -43.4%7.1%0.1 $13.43 9/30/2022573,400 shares $5.29 million -47.4%12.6%0.1 $9.23 9/15/20221,090,000 shares $9.88 million -31.9%24.0%0.2 $9.06 8/31/20221,600,000 shares $18.05 million +787.4%35.2%0.3 $11.28Charles Payne’s Gift to Stock Investors (Ad)Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET NERV Short Interest - Frequently Asked Questions What is Minerva Neurosciences' current short interest? Short interest is the volume of Minerva Neurosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 30,500 shares of NERV short. 0.56% of Minerva Neurosciences' shares are currently sold short. Learn More on Minerva Neurosciences' current short interest. What is a good short interest percentage for Minerva Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.56% of Minerva Neurosciences' floating shares are currently sold short. Is Minerva Neurosciences' short interest increasing or decreasing? Minerva Neurosciences saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 30,500 shares, a drop of 24.3% from the previous total of 40,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Minerva Neurosciences' float size? Minerva Neurosciences currently has issued a total of 6,990,000 shares. Some of Minerva Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Minerva Neurosciences currently has a public float of 5,440,000 shares. How does Minerva Neurosciences' short interest compare to its competitors? 0.56% of Minerva Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Minerva Neurosciences: Benitec Biopharma Inc. (0.50%), Orgenesis Inc. (1.17%), VBI Vaccines Inc. (2.65%), FSD Pharma Inc. (1.11%), KALA BIO, Inc. (0.21%), NeuroSense Therapeutics Ltd. (0.76%), Flora Growth Corp. (7.33%), Galecto, Inc. (0.09%), Alaunos Therapeutics, Inc. (9.51%), Talphera, Inc. (0.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Minerva Neurosciences stock? Short selling NERV is an investing strategy that aims to generate trading profit from Minerva Neurosciences as its price is falling. NERV shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Minerva Neurosciences? A short squeeze for Minerva Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NERV, which in turn drives the price of the stock up even further. How often is Minerva Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NERV, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BNTC Short Squeeze ORGS Short Squeeze VBIV Short Squeeze HUGE Short Squeeze KALA Short Squeeze NRSN Short Squeeze FLGC Short Squeeze GLTO Short Squeeze TCRT Short Squeeze TLPH Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NERV) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media4 coins to be the “Next Bitcoin”True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith